Opioid Endocrinopathy: A Clinical Problem in Patients With Chronic Pain and Long-term Oral Opioid Treatment
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Background: The use of strong opioids for treatment of noncancer chronic pain has increased. However, strong evidence for sustained pain relief and improved function is lacking. Controversy prevails, whether hormonal changes are induced by long-term treatment with opioids. The purpose of this study was to investigate the occurrence of endocrine dysfunction in chronic pain patients on long-term opioid treatment. Methods: A study group of 39 chronic pain patients treated with strong oral opioids for more than 1 year was compared with a control group of 20 chronic pain patients without opioid treatment. Basic levels of prolactin and function of the hypothalamic-pituitary-thyroid-, hypothalamic-pituitary-adrenal-axis, and hypothalamic-pituitary-growth-hormone - and hypothalamic-pituitary-gonadal-axis were measured. Quality-of-life and side effects were estimated with EORTC-QLQ-C30. Results: In the opioid-treated group, the patients had signs of pituitary dysfunction affecting all axes. Significant differences were shown in hypofunction of the hypothalamic-pituitary-gonadal -axis, hyperfunction of the hypothalamic-pituitary-adrenal -axis, and higher prolactin levels in the opioid-treated group, compared with the control group. The degree of pain was rated the same in both groups, but the opioid-treated group reported more side effects and lower quality of life. Conclusions: Long-term treatment of chronic pain with strong opioids causes side effects that can be attributed to hormonal abnormalities caused by opioid-induced inhibition of hypothalamic-pituitary function. Hormone substitution can be indicated to treat symptoms. Decreasing the opioid dose or stopping the opioid treatment can reverse endocrine dysfunction. This needs to be recognized by all practitioners treating chronic pain patients with opioids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study evaluated 39 noncancer pain patients who received different oral opioids and 20 controls (118); GH stimulation test was not performed but mean serum IGF-I was lower in the opioid-treated group, although statistical significance was not attained.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
In the citing paper
“Variable results have also been described for the peripheral thyroid hormones; T4 levels were unaffected (74, 118, 136, 159, 160) or decreased (116, 160-162) and T3 levels were increased (74, 159) or unaffected (160) or decreased (161).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
In the citing paper
“Studies with dynamic thyrotropin-releasing hormone test performed in chronic opioid users have demonstrated conflicting results with enhanced (118), blunted (136, 155, 156), or no (74, 157) TSH response.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
In the citing paper
“In a group of 39 noncancer pain patients on oral opioids, hyperprolactinemia was detected in approximately 40% of them (118).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
Kalso, E., Edwards, J. E., Moore, A. R., & McQuay, H. J. (2004) · Pain · doi:10.1016/j.pain.2004.09.019 · Cited by 1,216 · cited 1×
“Number 39 20 Gender (M/F) 15/24 8/12 Mean age (range) 48 (32-63) 49 (32-63) Mean years with pain (range) 13 (4-30) 12 (4-23) Causes of pain”
Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases
Portenoy, R. K., & Foley, K. M. (1986) · Pain · doi:10.1016/0304-3959(86)90091-6 · Cited by 897
Equianalgesic Dose Ratios for Opioids
Pereira, J., Lawlor, P., Vigano, A., Dorgan, M., & Bruera, E. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00294-9 · Cited by 537
Critical issues on opioids in chronic non-cancer pain:
Eriksen, J., Sjøgren, P., Bruera, E., Ekholm, O., & Rasmussen, N. K. (2006) · Pain · doi:10.1016/j.pain.2006.06.009 · Cited by 515
Endocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial
Gimbel, J. S., Richards, P., & Portenoy, R. K. (2003) · Neurology · doi:10.1212/01.wnl.0000057720.36503.2c · Cited by 469
Chronic Pain in Canada ‐ Prevalence, Treatment, Impact and the Role of Opioid Analgesia
Moulin, D. E., Clark, A. J., Speechley, M., & Morley-Forster, P. K. (2002) · Pain Research and Management · doi:10.1155/2002/323085 · Cited by 443
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Opioid Therapy for Chronic Noncancer Back Pain: A Randomized Prospective Study
Jamison, R. N., Raymond, S. A., Slawsby, E. A., Nedeljkovic, S. S., & Katz, N. P. (1998) · Spine · doi:10.1097/00007632-199812010-00014 · Cited by 298
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263 · cited 1×
“Number 39 20 Gender (M/F) 15/24 8/12 Mean age (range) 48 (32-63) 49 (32-63) Mean years with pain (range) 13 (4-30) 12 (4-23) Causes of pain”
Opioid analgesia: perspectives on right use and utility.
Ballantyne, J. C. (2007) · PubMed · Cited by 157
Daniell, H. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.04.011 · Cited by 144
Opioid Analgesia: Perspectives on Right Use and Utility
Ballantyne, J. C. (2007) · Pain Physician · doi:10.36076/ppj.2007/10/479 · Cited by 142
Clinical Characteristics of Chronic Back Pain as a Function of Gender and Oral Opioid Use
Fillingim, R. B., Doleys, D. M., Edwards, R. R., & Lowery, D. (2003) · Spine · doi:10.1097/00007632-200301150-00010 · Cited by 140
Altered sexual function and decreased testosterone in patients receiving intraspinal opioids
Pake, J. A., Penn, R. D., & Ryan, W. G. (1994) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)90166-x · Cited by 140
Sex Hormone Suppression by Intrathecal Opioids: A Prospective Study
Roberts, L. J., Finch, P. M., Pullan, P. T., Bhagat, C. I., & Price, L. M. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200205000-00002 · Cited by 128
Chronic fentanyl application induces adrenocortical insufficiency
OLTMANNS, K. M., FEHM, H. L., & PETERS, A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01483.x · Cited by 117
Endogenous Opioid Peptides and Hypothalamo-Pituitary Function
Howlett, T. A., & Rees, L. H. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.002523 · Cited by 105
Women with low libido: correlation of decreased androgen levels with female sexual function index
Turna, B., Apaydın, E., Semerci, B., Altay, B., Cikili, N., & Nazli, O. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901294 · Cited by 103
Morphine inhibits cortisol and stimulates prolactin secretion in man
Zis, A. P., Haskett, R. F., Ariav Albala, A., & Carroll, B. J. (1984) · Psychoneuroendocrinology · doi:10.1016/0306-4530(84)90050-7 · Cited by 96
Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy
Rajagopal, A., Vassilopoulou‐Sellin, R., Palmer, J. L., Kaur, G., & Bruera, E. D. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00331-2 · Cited by 95
Methadone Maintenance and Male Sexual Dysfunction
Brown, R., Balousek, S. L., Mundt, M. P., & Fleming, M. (2005) · Journal of Addictive Diseases · doi:10.1300/j069v24n02_08 · Cited by 92
The Value of Dehydroepiandrosterone Sulfate Measurements in the Assessment of Adrenal Function
Nasrallah, M. P., & Arafah, B. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030449 · Cited by 87
Geiss, A., Rohleder, N., Kirschbaum, C., Steinbach, K., Bauer, H. W., & Anton, F. (2005) · Pain · doi:10.1016/j.pain.2004.12.007 · Cited by 68
Faletti, A. G., Mastronardi, C. A., Lomniczi, A., Seilicovich, A., Gimeno, M., McCann, S. M., & Rettori, V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1722 · Cited by 60
Schluger, J. H., Bart, G. B., Green, M., Ho, A., & Kreek, M. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300156 · Cited by 57
Dehydroepiandrosterone: a springboard hormone for female sexuality
Spark, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02987-4 · Cited by 50
Chronic Nonmalignant Pain Treated with Long-Term Oral Narcotic Analgesics
Bouckoms, A., Masand, P., Murray, G., Cassem, E., Stern, T., & Tesar, G. (1992) · Annals of Clinical Psychiatry · doi:10.3109/10401239209149570 · Cited by 49
Pain questionnaires in the analysis of long lasting (chronic) pain conditions
Wincent, A., Lidén, Y., & Arnér, S. (2003) · European Journal of Pain · doi:10.1016/s1090-3801(03)00044-2 · Cited by 48
Johansson, A., Gunnarsson, L., Linton, S. J., Bergkvist, L., Stridsberg, M., Nilsson, O., & Cornefjord, M. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2007.10.009 · Cited by 45
Self-citationPalm, S., Moenig, H., & Maier, C. (1997) · PubMed · Cited by 42
Musculo-skeletal pain, psychological distress, and hormones during the menopausal transition
Finset, A., Øverlie, I., & Holte, A. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00134-8 · Cited by 30
Dehydroepiandrosterone Replacement Therapy
Arlt, W. (2001) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-861554 · Cited by 25
Carr, J. A., & Lovering, A. T. (2000) · Neuropeptides · doi:10.1054/npep.1999.0793 · Cited by 20
Cited by
Portenoy, R. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60236-5 · Cited by 487
Stein, C. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-062613-093100 · Cited by 480
McNicol, E. D., Midbari, A., & Eisenberg, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006146.pub2 · Cited by 434
Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women
Bateman, B. T., Franklin, J. M., Bykov, K., Avorn, J., Shrank, W. H., Brennan, T. A., Landon, J. E., Rathmell, J. P., Huybrechts, K. F., Fischer, M. A., et al. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.03.016 · Cited by 286
A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner’s Guide
Baldini, A., Von Korff, M., & Lin, E. H. B. (2012) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.11m01326 · Cited by 260
Metadata
- Authors
- Rhodin, A., Stridsberg, M., & Gordh, T.
- Affiliations
- Uppsala University Hospital (SE)
- Corresponding author
- Rhodin, Annica
- Gordh, Torsten
- Venue
- The Clinical Journal of Pain
- Published
- 2010-06
- Volume
- 26
- Issue
- 5
- Pages
- 374-380
- ISSN
- 0749-8047 (ISSN-L)
- OpenAlex
- W2122866774
- Semantic Scholar
- 7f03806c4c29c1464ecc1c49a8b90e6490bbf01d
- Cited by
- 142
- References
- 36
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 6 · 2023: 5 · 2022: 12 · 2021: 15 · 2020: 12 · 2019: 13 · 2018: 11 · 2017: 5 · 2016: 5 · 2015: 10 · 2014: 12 · 2013: 9 · 2012: 9
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Journal of Pain (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- long-term opioid therapy, chronic non-cancer pain, prolactin, hypothalamic-pituitary-gonadal axis, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-thyroid axis, endocrine dysfunction, quality of life, opioid side effects, hormone replacement therapy
- MeSH terms
- Adult, Analgesics, Opioid, Chronic Disease, Drug Administration Schedule, Endocrine System Diseases, Estradiol, Female, Health Status, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Menstrual Cycle, Middle Aged, Pain, Pain Measurement, Pituitary Hormones, Anterior, Pituitary-Adrenal System, Quality of Life, Testosterone, Patient Selection, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.